Bellicum Pharmaceuticals, Inc. (BLCM) Financials

BLCM Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 6.9 million 33.9 million
2023-06-30 8.7 million 30.6 million
2023-03-31 17.3 million 27.3 million
2022-12-31 23.8 million 21.8 million

BLCM Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -1.5 million 116000
2023-06-30 -8.0 million 59000
2023-03-31 -6.4 million 559000
2022-12-31 -6.9 million 714000

BLCM Net Income

No data available :(

BLCM Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 5.9 million - -
2023-06-30 7.4 million - -
2023-03-31 15.4 million - -
2022-12-31 21.8 million - -

BLCM Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 30.9 million
2023-06-30 30.8 million
2023-03-31 30.8 million
2022-12-31 5.8 million

BLCM Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 - 263000 1.5 million -
2023-06-30 1000 4.8 million 2.3 million -
2023-03-31 5000 7.2 million 1.4 million -
2022-12-31 7000 6.3 million 1.5 million -

BLCM Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 1.0 million -
2023-06-30 - -
2023-03-31 8000 -
2022-12-31 500000 -

BLCM

Price: $0.07

52 week price:
0.06
1.43

Earnings Per Share: -0.72 USD

P/E Ratio: -0.13

Exchange: PNK

Sector: Healthcare

Industry: Biotechnology

Volume: 39500

Ebitda: -21.5 million

Market Capitalization: 778326

Links: